Abstract
BackgroundInternational differences in survival among colorectal cancer (CRC) patients may partly be explained by differences in emergency presentations (EP), waiting times and access to treatment.MethodsCRC patients registered in 2015–2016 at the Cancer Registry of Norway were linked with the Norwegian Patient Registry and Statistics Norway. Multivariable logistic regressions analysed the odds of an EP and access to surgery, radiotherapy and systemic anticancer treatment (SACT). Multivariable quantile regression analysed time from diagnosis to treatment.ResultsOf 8216 CRC patients 29.2% had an EP before diagnosis, of which 81.4% were admitted to hospital with a malignancy-related condition. Higher age, more advanced stage, more comorbidities and colon cancer were associated with increased odds of an EP (p < 0.001). One-year mortality was 87% higher among EP patients (HR=1.87, 95%CI:1.75–2.02). Being married or high income was associated with 30% reduced odds of an EP (p < 0.001). Older age was significantly associated with increased waiting time to treatment (p < 0.001). Region of residence was significantly associated with waiting time and access to treatment (p < 0.001). Male (OR = 1.30, 95%CI:1.03,1.64) or married (OR = 1.39, 95%CI:1.09,1.77) colon cancer patients had an increased odds of SACT. High income rectal cancer patients had an increased odds (OR = 1.48, 95%CI:1.03,2.13) of surgery.ConclusionPatients who were older, with advanced disease or more comorbidities were more likely to have an emergency-onset diagnosis and less likely to receive treatment. Income was not associated with waiting time or access to treatment among CRC patients, but was associated with the likelihood of surgery among rectal cancer patients.
Highlights
International differences in survival among colorectal cancer (CRC) patients may partly be explained by differences in emergency presentations (EP), waiting times and access to treatment
The proportion of patients diagnosed through an emergency presentation (EP), waiting times from diagnosis to treatment, and access to treatment are all contributing factors that may explain some of the observed variation and potentially affect survival
Patient characteristics Of these 8216 patients diagnosed with colorectal cancer in 2015–2016 in Norway, 5677 (69.1%) had colon cancer and 2539 (30.9%) rectal cancer (Table 1)
Summary
International differences in survival among colorectal cancer (CRC) patients may partly be explained by differences in emergency presentations (EP), waiting times and access to treatment. In Norway in 2015–2019, the five-year net survival among colon cancer patients was estimated to be 68.1% in males and 71.1% in females while for rectal cancer it was 71.1 and 71.5%, respectively [2]. Considerable variation in survival has been reported for colon and rectal cancers both internationally and nationally [3,4,5,6]. The proportion of patients diagnosed through an emergency presentation (EP), waiting times from diagnosis to treatment, and access to treatment are all contributing factors that may explain some of the observed variation and potentially affect survival
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have